Quick answers
- Is CVE-2026-12646 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-12646 being exploited in the wild.
- How severe is CVE-2026-12646?
- Critical severity, with a CVSS score of 9.9, published 8 September 2026.
- Which products and versions are affected?
- Ivanti Neurons for ITSM before 2026.2.
- Is there a fix for CVE-2026-12646?
- No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-12646 attacked?
- It is attacked over the network.
- Am I affected by CVE-2026-12646?
- Check whether you run Ivanti Neurons for ITSM at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
Technical details
This is a missing authorization vulnerability (CWE-862) in Ivanti Neurons for ITSM versions before 2026.2. The vulnerability requires authentication but fails to properly validate that the authenticated user is authorized to perform sensitive operations, specifically arbitrary code execution. The flaw exists in the application's access control logic, allowing a remote authenticated attacker to execute arbitrary code on the server. This vulnerability has a CVSS score of 9.9 (critical), indicating severe impact. No evidence of active exploitation in the wild has been reported, but patched versions are available.
Affected products
- Ivanti Neurons for ITSM before 2026.2
Timeline
- 2026-09-08: disclosed